Express News | Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
ReutersApr 25 16:05 ET
Cardiff Oncology Reveals Latest Cancer Research at AACR
TipRanksApr 8 16:23 ET
Cardiff Oncology Presents Novel Preclinical Data At AACR Annual Meeting 2024; Supports First-Line RAS-Mutated MCRC Clinical Study
– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor's ability to adapt to hypoxia resulting in a significant decrease in both tumor vascularization and growth
BenzingaApr 8 16:06 ET
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Yahoo FinanceMar 14 08:08 ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersHeron Therapeutics (NASDAQ:HRTX) shares rose 35.4% to $3.19 during Wednesday's regular session. The market value of their outstanding shares is at $479.4 million. The company's, Q4 earnings cam
BenzingaMar 13 13:31 ET
ETRN, CRDF and KC Are Among Pre Market Gainers
Seeking AlphaMar 11 09:30 ET
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
Globe NewswireMar 6 16:05 ET
Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.
Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 6 06:59 ET
Express News | HC Wainwright & Co. Maintains Buy on Cardiff Oncology, Raises Price Target to $14
Moomoo 24/7Mar 6 06:49 ET
Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39,007.30 while the NASDAQ fell 0.18% to 16,245.77. The S&P 500 also fell, dro
BenzingaMar 4 14:34 ET
We Think Cardiff Oncology (NASDAQ:CRDF) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares
Simply Wall StMar 4 09:07 ET
MINM, RMCO and GRFS Among Pre-market Losers
Seeking AlphaMar 4 08:17 ET
Cardiff Oncology Full Year 2023 Earnings: Beats Expectations
Yahoo FinanceMar 3 08:40 ET
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 2 08:10 ET
Sector Update: Health Care
Health care stocks rose late Friday afternoon with the NYSE Health Care Index adding 0.9% and the Health Care Select Sector SPDR Fund (XLV) increasing 1%. The iShares Biotechnology ETF (IBB) gained 2.
MT NewswiresMar 1 15:37 ET
Cardiff Oncology Shares Jump, Discontinued Cancer Treatment Trial Shows Efficacy
Cardiff Oncology (CRDF) shares were up nearly 40% in Friday trading after the company said late Thursday that data from the now-discontinued trial of onvansertib underpinned its effectiveness as a fir
MT NewswiresMar 1 14:32 ET
Earnings Call: Cardiff Oncology Reports Promising Trial Results, Extends Cash Runway
InvestingMar 1 13:50 ET
MTC , ENCP and MINM Among Mid-day Movers
Seeking AlphaMar 1 12:50 ET
Nasdaq Surges 100 Points; ISM Manufacturing PMI Falls In February
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Friday. The Dow traded up 0.02% to 39,005.87 while the NASDAQ rose 0.63% to 16,193.95. The S&P
BenzingaMar 1 12:16 ET
Small Cap-Cardiff Oncology Outlines Data From Discontinued Colorectal Cancer Trial, Stock Soars
Cardiff Oncology Inc (NASDAQ:CRDF) provided a clinical update on the first release of data from its ONSEMBLE trial of onvansertib in combination with FOLFIRI/bev in patients with second-line RAS-mutat
BenzingaMar 1 11:38 ET
No Data
No Data